The use of dopamine agonists in Parkinson's disease treatment

被引：0
|
作者：
Gekht, AB [1 ]
机构：
[1] Russian State Med Univ, Chair Neurol & Neurosurg, Moscow 117437, Russia
来源：
ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2002年 / 102卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：54 / 58
页数：5
相关论文
共 50 条
  • [41] Dopamine agonists and sleep in Parkinson's disease
    Cantor, CR
    Stern, MB
    NEUROLOGY, 2002, 58 (04) : S71 - S78
  • [42] Dopamine agonists and neuroprotection in Parkinson's disease
    Olanow, CW
    Jenner, P
    Brooks, D
    ANNALS OF NEUROLOGY, 1998, 44 (03) : S167 - S174
  • [43] Dopamine receptor agonists for Parkinson's disease
    Blandini, Fabio
    Armentero, Marie-Therese
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) : 387 - 410
  • [44] Are Dopamine Agonists Neuroprotective in Parkinson′s Disease?
    乐卫东
    J Jankovic
    Journal of Nanjing Medical University, 2002, (01) : 40 - 48
  • [45] Choosing dopamine agonists in Parkinson's disease
    Jankovic, J
    Tan, EK
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (05) : 247 - 253
  • [46] Use of dopamine analogs in Parkinson's disease treatment
    Gekht, AB
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2002, 102 (12): : 53 - 55
  • [47] Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease
    Gerlach, M
    Double, K
    Reichmann, H
    Riederer, P
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2003, (65): : 167 - 183
  • [48] Rationale for use of dopamine agonists in Parkinson's disease: Review of ergot derivatives
    Blanchet, PJ
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S21 - S26
  • [49] Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease
    Gerlach, M
    Double, K
    Reichmann, H
    Riederer, P
    ADVANCES IN RESEARCH ON NEURODEGENERATION, 2003, 10 : 167 - 183
  • [50] Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease - Discussion
    Olanow
    Schapira
    Isacson
    Rascol
    Brooks
    Tatton
    Marek
    Beal
    Jenner
    Stocchi
    ANNALS OF NEUROLOGY, 2003, 53 : S157 - S159
12345